New FDA guidance is pushing sponsors to strengthen diversity in clinical research, but some sites are already ahead of the curve.
In this new case study, CRIO analyzed data from over 60,000 subjects across 644 sites and uncovered a powerful trend: Sites using CRIO’s eSource platform enroll more than twice as many Black or African American participants as the national average.
Inside the Case Study
Learn how CRIO-enabled sites are setting a new standard for inclusion and performance. This data-driven analysis explores:
- How CRIO sites achieved an average of 17.5% Black or African American participants, compared to the FDA-reported 8% national average.
- Why technology-enabled workflows help sites expand access to underrepresented communities.
- Real examples from sites who have built trust and engagement in diverse populations.
- How sponsors can leverage CRIO’s network to meet and exceed FDA diversity goals.
Key Takeaway
CRIO sites aren’t just enrolling faster, they’re enrolling more equitably. This case study demonstrates how eSource technology can be a catalyst for both diversity and data quality in clinical trials.